Skip to main content

cPMP Substrate Replacement Therapy Drugs

cPMP substrate replacement therapy drugs are used to treat Molybdenum Cofactor Deficienty Type A, a rare metabolic disease. They work by replacing missing cPMP in the body.

Why are cpmp substrate replacement therapy drugs prescribed?

  1. Inherited Metabolic Diseases (100%)

Key takeaways

Cyclic pyranopterin monophosphate (cPMP) substrate replacement therapy is used to treat a genetic condition called molybdenum cofactor deficiency (MoCD) Type A. It work by replacing missing enzymes in the body to help breakdown toxic compounds. An example is Nulibry (fosdenopterin) that's typically infused through the veins.

Prices for popular cPMP Substrate Replacement Therapy Drugs medications
Viewing 1 of 1 medications
vial icon

Nulibry

as low as$3
FOSDENOPTERIN treats molybdenum cofactor deficiency (MoCD). It works by replacing a substance normally made by the body, which reduces the buildup of toxins. This reduces injury to the brain.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.

Subscribe and save

Get prescription saving tips and more from GoodRx Health. Enter your email to sign up

By signing up, I agree to GoodRx’s Terms of Use and Privacy Policy, and to receive marketing messages from GoodRx.

Browse medications

View All
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.